Legal Opinion
Glaxo Group Limited and Smithkline Beecham Corp. v. Apotex, Inc.
Court of Appeals for the Federal Circuit
Decided September 10, 2004No. 03-1575PublishedCited by 71 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge GAJARSA. Opinion concurring-in-part and dissenting-in-part filed by Circuit Judge DYK.
GAJARSA, Circuit Judge.
Apotex, Inc. (“Apotex”) appeals the judgment of the United States District Court for the Northern District of Illinois, which found that Apotex’s filing of an Abbreviated New Drug Application (“ANDA”) for a generic version of the antibiotic Ceftin® willfully infringed U.S. Patent No. 4,562,181 (the “'181 patent”) and U.S. Patent No. 4,820,833 (the “'833 patent”) owned by Glaxo Group Limited and SmithKline Beecham Corp. (collectively…
2Cases cited33 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- University of Texas v. CamenischSupreme Court of the United States · 1981
- Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-CrossCourt of Appeals for the Federal Circuit · 1998
28 more not listed; retrieve them via the Exa API.
3Cited by71 opinions
- Net MoneyIN, Inc. v. VeriSign, Inc.Court of Appeals for the Federal Circuit · 2008
- Sanofi-Synthelabo v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2006
- Caraco Pharmaceutical Laboratories, Ltd. v. Forest Laboratories, Inc.Court of Appeals for the Federal Circuit · 2008
- Abraxis Bioscience, Inc. v. NAVINTA LLCCourt of Appeals for the Federal Circuit · 2010
- Liebel-Flarsheim Company and Mallinckrodt, Inc. v. Medrad, Inc., Defendant-CrossCourt of Appeals for the Federal Circuit · 2007
66 more not listed; retrieve them via the Exa API.